ecteinascidin 743 has been researched along with cytochrome c-t in 1 studies
Studies (ecteinascidin 743) | Trials (ecteinascidin 743) | Recent Studies (post-2010) (ecteinascidin 743) | Studies (cytochrome c-t) | Trials (cytochrome c-t) | Recent Studies (post-2010) (cytochrome c-t) |
---|---|---|---|---|---|
660 | 102 | 404 | 11,809 | 21 | 5,125 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atmaca, H; Bozkurt, E; Karaca, B; Uslu, R; Uzunoglu, S | 1 |
1 other study(ies) available for ecteinascidin 743 and cytochrome c-t
Article | Year |
---|---|
A diverse induction of apoptosis by trabectedin in MCF-7 (HER2-/ER+) and MDA-MB-453 (HER2+/ER-) breast cancer cells.
Topics: Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; bcl-Associated Death Protein; Breast Neoplasms; Caspase 3; Caspase 7; Cell Line, Tumor; Cytochromes c; Dioxoles; Female; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; MCF-7 Cells; Mitochondria; Mitochondrial Proteins; Reactive Oxygen Species; Receptors, TNF-Related Apoptosis-Inducing Ligand; Tetrahydroisoquinolines; Trabectedin | 2013 |